Tetrabenazine MR + Placebo
Phase 2Withdrawn 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tourette's Syndrome
Conditions
Tourette's Syndrome
Trial Timeline
Mar 1, 2011 → Dec 1, 2011
NCT ID
NCT01133353About Tetrabenazine MR + Placebo
Tetrabenazine MR + Placebo is a phase 2 stage product being developed by Bausch Health for Tourette's Syndrome. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01133353. Target conditions include Tourette's Syndrome.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01133353 | Phase 2 | Withdrawn |
Competing Products
2 competing products in Tourette's Syndrome
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| PF-03654746 + Placebo + Placebo + PF-03654746 | Pfizer | Phase 2 | 51 |
| Aripiprazole | Bristol Myers Squibb | Pre-clinical | 22 |